Complimentary Learning Level: Intermediate Risk Assessments are a core part of regulatory compliance, but many lab organizations struggle to properly scale their Computerized System Validation (CSV) activities based on...
Learning Level: Intermediate Over the last several decades, the complexity of the pharmaceutical industry has increased immensely. Today, large pharmaceutical companies deal with higher product volumes, more diverse SKUs...
Learning Level: Basic/Intermediate - Analytical laboratories are required to demonstrate the suitability of their equipment during audits and will typically follow USP requirements defined in Chapter <1058> on analytical...
Learning Level: Intermediate - Because of their hidden nature, critical utility systems are vulnerable to non-compliance. With their potential to impact product quality or performance in a significant way, critical...
Learning Level: Basic/Intermediate - What is Pharma 4.0? It is a vision of a holistic company-wide transformation, which balances and combines: productivity, quality, and robustness based on a data-centric perspective...
Insights into NEW ISPE Guide: Cleaning Validation Lifecycle – Applications, Methods, & Controls Webinar Learning Level: Basic/Intermediate/Advanced - This Webinar summarizes the recently published ISPE Guide on Cleaning...
Complimentary Learning Level: Basic With COVID-19 very suddenly forcing our entire world to rethink the way we interact and do business, ISPE found itself propelled into largely uncharted territory of virtual exhibits...
As we’re all navigating our way through 2020 and making the most of our virtual interactions, we would like to connect you with the leadership at ISPE through our new webinar series ISPE Member Connect. This informative...
Learning Level: Basic - Drug shortages are not just a supply chain problem. They are a problem for patients. Sometimes these patients are so at risk, resolving the shortage could make the ultimate difference. During this...
Learning Level: Basic/Intermediate - Sponsored by: Hold times caused by micro QC test have a significant impact on the manufacturing cycle. Many companies try to overcome this bottle neck by choosing a “continue at risk”...
